Puxin Stock Forecast, Price & News

-0.01 (-1.85 %)
(As of 09/16/2021 02:12 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume9,854 shs
Average Volume1.17 million shs
Market Capitalization$46.36 million
P/E Ratio17.67
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive NEW News and Ratings via Email

Sign-up to receive the latest news and ratings for Puxin and its competitors with MarketBeat's FREE daily newsletter.

About Puxin

Puxin Ltd. provides educational services. It offers K-12 tutoring services, which provide educational services in various forms, such as classroom-based after-school tutoring, as well as full-time tutoring for preparation of university entrance exams and art college admission exams, to help students enhance their academic results. The firm operates through the following segments: K-12 tutoring services and Study Abroad tutoring services. The company was founded by Yun Long Sha in September 2014 and is headquartered in Beijing, China.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.00 out of 5 stars

Consumer Discretionary Sector

342nd out of 385 stocks

Educational Services Industry

35th out of 50 stocks

Analyst Opinion: 0.0Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Puxin (NYSE:NEW) Frequently Asked Questions

What stocks does MarketBeat like better than Puxin?

Wall Street analysts have given Puxin a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Puxin wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Puxin?

Puxin saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 1,470,000 shares, an increase of 50.2% from the August 15th total of 978,900 shares. Based on an average trading volume of 2,060,000 shares, the days-to-cover ratio is presently 0.7 days.
View Puxin's Short Interest

When is Puxin's next earnings date?

Puxin is scheduled to release its next quarterly earnings announcement on Monday, September 20th 2021.
View our earnings forecast for Puxin

How has Puxin's stock price been impacted by COVID-19 (Coronavirus)?

Puxin's stock was trading at $7.03 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, NEW shares have decreased by 92.5% and is now trading at $0.53.
View which stocks have been most impacted by COVID-19

What guidance has Puxin issued on next quarter's earnings?

Puxin issued an update on its second quarter 2021 earnings guidance on Tuesday, June, 22nd. The company provided earnings per share (EPS) guidance of $- for the period. The company issued revenue guidance of $100.92 million-105.51 million.

Who are Puxin's key executives?

Puxin's management team includes the following people:
  • Yun Long Sha, Chairman & Chief Executive Officer
  • Peng Wang, Chief Financial Officer

Who are some of Puxin's key competitors?

What other stocks do shareholders of Puxin own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Puxin investors own include Ampio Pharmaceuticals (AMPE), Trevena (TRVN), Stride (LRN), Pfizer (PFE), Advanced Micro Devices (AMD), ChromaDex (CDXC), Chimerix (CMRX), CorMedix (CRMD), CTI BioPharma (CTIC) and DRDGOLD (DRD).

When did Puxin IPO?

(NEW) raised $133 million in an IPO on Friday, June 15th 2018. The company issued 7,200,000 shares at $17.00-$20.00 per share. Citigroup, Deutsche Bank Securities, Barclays, Haitong International and CICC served as the underwriters for the IPO.

What is Puxin's stock symbol?

Puxin trades on the New York Stock Exchange (NYSE) under the ticker symbol "NEW."

Who are Puxin's major shareholders?

Puxin's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Morgan Stanley (1.34%), Morgan Stanley (1.34%), JPMorgan Chase & Co. (0.96%), Goldman Sachs Group Inc. (0.54%), Bank of America Corp DE (0.31%) and Squarepoint Ops LLC (0.10%).

Which institutional investors are selling Puxin stock?

NEW stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Balyasny Asset Management LLC, and State Street Corp.

Which institutional investors are buying Puxin stock?

NEW stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley, Morgan Stanley, Bank of America Corp DE, Goldman Sachs Group Inc., Squarepoint Ops LLC, Susquehanna International Group LLP, Citadel Advisors LLC, and Cutler Group LP.

How do I buy shares of Puxin?

Shares of NEW can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Puxin's stock price today?

One share of NEW stock can currently be purchased for approximately $0.53.

How much money does Puxin make?

Puxin has a market capitalization of $46.36 million and generates $445.04 million in revenue each year.

How many employees does Puxin have?

Puxin employs 9,650 workers across the globe.

What is Puxin's official website?

The official website for Puxin is www.pxjy.com.

Where are Puxin's headquarters?


How can I contact Puxin?

Puxin's mailing address is FLOOR 16 CHUANGFU MANSION NO. 18 DANLING STREET HAIDIAN DISTRICT, BEIJING F4, 100080. The company can be reached via phone at 861082605578 or via email at [email protected]

This page was last updated on 9/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.